Monday, March 13, 2017 3:20:29 PM
http://aquabounty.com/about/leadership/
Ronald L. Stotish – Executive Director, President and Chief Executive Officer.
Ronald L. Stotish, Ph.D. was appointed an Executive Director, President and CEO of AquaBounty Technologies in May 2008. Dr. Stotish joined AquaBounty Technologies in 2006 as Vice President for Regulatory Affairs, and most recently was Senior Vice President for R&D and Regulatory Affairs. Prior to joining AquaBounty, Dr. Stotish was Executive Vice President for R&D at MetaMorphix, Inc. He has served as Vice President for Pharmaceutical Research and Development at Fort Dodge Animal Health, and held a variety of positions at American Cyanamid. He began his career in research at Merck. Dr. Stotish has degrees in biochemistry and over 40 years experience in the discovery, development, and commercialization of new animal health products.
David A. Frank – Chief Financial Officer and Treasurer
David Frank was appointed CFO in October 2007. Previously he served as President and General Manager of TekCel LLC, a subsidiary of Magellan Biosciences, after serving as Magellan’s CFO since the company’s founding in 2004 and as TekCel’s CFO since 2003. Mr. Frank has over 28 years of financial-management experience, including as CFO of SmartEnergy during its period of rapid growth from less than $1 million in revenue in 2000 to more than $45 million in 2002. He served as the corporate controller for Moldflow when the company completed its successful public offering and his earlier experience includes financial roles at PerSeptive Biosystems, Lotus Development Corporation, Apollo Computer, and Honeywell. He has a BS in finance and accounting from Boston College and an MBA from Babson College.
Henry Clifford – Vice-President of Marketing & Sales
Henry Clifford was appointed Vice-President of Marketing & Sales in June 2005 and is responsible for the commercial deployment of the company’s product lines. Mr. Clifford is an internationally recognized authority on aquaculture and genetic improvement programs with a career spanning more than 30 years in the industry. He has provided technical services in aquaculture to more than 250 clients in 20 countries. In addition to implementing sales and marketing strategies for the company and overseeing customer relations, Mr. Clifford directs domestic and international field trial evaluations of the company’s products, including the successful introduction and production of AquAdvantage Salmon in Panama. Mr. Clifford has a M.S. degree in aquaculture nutrition from Texas A&M University.
Alejandro Rojas, DVM – Chief Operating Officer
Alejandro Rojas joined AquaBounty as the Chief Operating Officer of its AquaBounty Farms division in February 2014. He formerly was the Production and Technical Manager for Marine Harvest from 1988 to 2000. Mr Rojas has a doctorate in veterinary medicine and for the past 14 years has been a technical advisor and consultant to numerous global aquaculture and biotech companies working with marine fish.
Christopher Martin – General Counsel and Corporate Secretary
Mr. Martin has served as our General Counsel since June 2015 and as our Corporate Secretary since July 2015. Prior to joining AquaBounty, he was Assistant General Counsel at athenahealth, Inc. from 2012 to 2014 and Senior Corporate Counsel from 2008 to 2012. He also served as Corporate Counsel at LeMaitre Vascular, Inc. from 2006 to 2008 and practiced in the areas of commercial, corporate, finance, and intellectual property law with Hemenway & Barnes LLP in Boston and Cummings & Lockwood LLC in Connecticut. Mr. Martin holds a Bachelor of Arts from Stanford University and a Juris Doctor from the University of California, Berkeley (Boalt Hall).
<<<
Recent AQB News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 12:05:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 12:28:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 12:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:03:37 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/24/2024 12:01:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 12:16:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:03:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 01:04:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 01:13:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 01:03:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 12:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 12:44:07 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM